E
Annovis Bio, Inc. ANVS
$2.87 -$0.14-4.65% NYSE
Recommendation
Prev Close
$3.01
Volume
324,241
Avg Vol (90D)
1,452,332
Market Cap
$79.77M
Dividend & Yield
--
52-Week Range
$1.11 - $5.50
P/E (TTM)
--
EPS (TTM)
-$1.49
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Annovis Bio, Inc. (NYSE:ANVS) Receives Average Recommendation of "Hold" from Analysts
1/21/2026 - MarketBeat
Annovis Bio (ANVS, $3.92) Aroon Indicator entered a Downtrend on January 08, 2026.
1/9/2026 - Tickeron - Stocks
Annovis Bio (ANVS, $4.07) Aroon Indicator entered a Downtrend on January 07, 2026.
1/8/2026 - Tickeron - Stocks
Annovis Bio (ANVS, $4.07) price may drop as it broke higher Bollinger Band on Jan 07, 2026
1/8/2026 - Tickeron - Stocks
Annovis Bio (ANVS, $3.85) Aroon Indicator entered a Downtrend on January 06, 2026.
1/7/2026 - Tickeron - Stocks
Annovis Bio (ANVS, $3.8) Aroon Indicator entered a Downtrend on January 05, 2026.
1/6/2026 - Tickeron - Stocks
Annovis Bio, Inc. (NYSE:ANVS) Given Consensus Rating of "Hold" by Analysts
12/27/2025 - MarketBeat
Annovis Bio (ANVS) Plans 2026 Study on Buntanetap for Parkinson's
12/18/2025 - GuruFocus
Annovis Bio reports open-label extension study for Parkinson's disease patients
12/18/2025 - TipRanks Financial Blog
Annovis Bio reports open-label extension study for Parkinson's disease patients
12/18/2025 - The Fly
Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
12/18/2025 - Globe Newswire
Annovis Bio Advances Long-Term Buntanetap Safety Study in Parkinson's Disease
12/18/2025 - TipRanks Financial Blog
Annovis to Host Corporate Update Webinar on January 28, 2026
12/16/2025 - Globe Newswire
Video: Friday 12/12 Insider Buying Report: ANVS, ECL
12/12/2025 - Market News Video
Annovis Bio (ANVS, $4.2) Stochastic Oscillator left the oversold zone on December 10, 2025
12/11/2025 - Tickeron - Stocks
Annovis Bio (ANVS, $4.2) entered Downtrend as Momentum indicator drops below 0 level on Dec 10, 2025
12/11/2025 - Tickeron - Stocks
Annovis Bio (ANVS, $4.46) Aroon Indicator entered an Uptrend on December 09, 2025.
12/10/2025 - Tickeron - Stocks
Annovis Bio (ANVS, $4.46) Moving Average Convergence Divergence (MACD) Histogram turned negative on December 9, 2025
12/10/2025 - Tickeron - Stocks
Annovis Bio (ANVS, $4.3) Aroon Indicator entered an Uptrend on December 08, 2025.
12/9/2025 - Tickeron - Stocks
Insider Buying: Annovis Bio (NYSE:ANVS) Director Buys 45,000 Shares of Stock
12/9/2025 - MarketBeat
Annovis Bio (NYSE:ANVS) Director Purchases $193,950.00 in Stock
12/9/2025 - MarketBeat
Annovis Bio (ANVS, $4.55) Aroon Indicator entered an Uptrend on December 05, 2025.
12/6/2025 - Tickeron - Stocks
Annovis Bio (ANVS, $4.55) RSI Indicator left the overbought zone on December 05, 2025
12/6/2025 - Tickeron - Stocks
Annovis Bio (ANVS, $4.65) Aroon Indicator entered an Uptrend on December 04, 2025.
12/5/2025 - Tickeron - Stocks
Brokerages Set Annovis Bio, Inc. (NYSE:ANVS) PT at $13.50
12/5/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$26.72M
Net Income (TTM)
-$24.88M
Balance Sheet
Total Assets (Q)
$17.19M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$4.03M
Book Value Per Share (Q)
$0.6517
Cash Flow
Cash from Operations (TTM)
-$24.98M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$27.63M
Net Change in Cash (TTM)
$2.65M
Filings
Filing Date
Wednesday, November 12, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
1.25
7-Day Total Return
-9.46%
30-Day Total Return
-31.67%
60-Day Total Return
36.67%
90-Day Total Return
21.10%
Year to Date Total Return
-21.37%
1-Year Total Return
-41.67%
2-Year Total Return
-68.43%
3-Year Total Return
-77.11%
5-Year Total Return
-72.67%
52-week Low
Apr 09, 2025 - $1.11
52-week High
Nov 28, 2025 - $5.50
Valuation
Market Cap
$79.77M - Micro Cap
Enterprise Value
$64.49M
Price/Sales (TTM)
--
Price/Book (Q)
4.62
Dividends and Shares
Shares Outstanding
19.69M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.annovisbio.com
Phone Number
484 875 3192
Address
101 Lindenwood Drive
Malvern, PA 19355
Country
United States
Year Founded
2008
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase... more
NYSE 01/26/2026 1:24PM Eastern Quotes delayed